Consumer telehealth · Online menopause care
Midi Health
Midi Health is a virtual clinic for women in perimenopause, menopause, and midlife, where clinicians trained in women's hormonal health treat symptoms by video visit and bill most major insurance plans.
Strong fit
- Insured women in perimenopause or menopause who want visits billed to their plan
- Women who want hormone therapy, testosterone, weight care, and other midlife care from one clinic
- Patients who want prescriptions sent to their own pharmacy
Weak fit
- Medicare and Medicaid patients who need coverage
- Patients who want refills without a paid follow-up visit
- People who cannot confirm appointments by text on short notice
Bottom line
Midi Health is a virtual women's clinic for perimenopause, menopause, and midlife care that bills most major insurance plans. It suits insured women who want an expert clinician by video and a broad treatment menu. Patients on Medicare or Medicaid, and those who want refills with no visit, should look elsewhere.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Midi Health is used by women in perimenopause, menopause, and midlife, many of whom say a regular doctor dismissed their symptoms. Clinicians see patients by video, prescribe hormone therapy and other treatments, and send prescriptions to the patient's pharmacy. Midi says more than 500,000 women have used it, and its February 2026 funding release put the number of patients it sees each week above 25,000.
Midi is priced for patients with insurance. It is in-network with most PPO plans, so many patients pay only a copay or their deductible. Self-pay visits cost $250 for a 30-minute first visit and $150 for a 15-minute return visit, more per visit than Evernow's $150 self-pay video visit and well above Alloy's $49 one-time consult fee.
The closest competitors are Evernow, which also bills insurance for video visits, Alloy and Winona, which sell cash-pay care, and Allara Health, which covers hormonal and metabolic conditions such as PCOS.
Joanna Strober, who earlier founded the childhood obesity program Kurbo and sold it to Weight Watchers, is co-founder and chief executive. Sharon Meers, a former Goldman Sachs managing director, is president and co-founder, and Kathleen Jordan, MD, is co-founder and chief medical officer, according to Midi's leadership page.
The treatment menu has grown well past hormone therapy. Midi added testosterone therapy for women in October 2025, launched a supplement line in August 2025 that reached Ulta Beauty stores in September 2026, and on October 14, 2026 began treating urinary tract infections, bacterial vaginosis, and yeast infections, according to its newsroom. It also prescribes GLP-1 weight medications and posts self-pay GLP-1 prices.
Business Insider reported in October 2025 that Midi had reached a $150 million annual revenue run rate, up from about $60 million at the end of 2024. In February 2026 Midi announced a $100 million Series D led by Goodwater Capital at a valuation above $1 billion, and said its insurance coverage reaches more than 45 million women.
The complaints cluster around booking and billing. Midi cancels appointments that are not confirmed by text within a set window, and several patients describe losing visits that way. Others object to paying for a follow-up visit to keep refills going. Medicare is out of network, so patients who turn 65 move to self-pay.
What patients say
Patients on Trustpilot rate Midi Health 4.1 from 1,773 reviews. Here is what they like and dislike.
"My own doctors have dismissed my symptoms as something. I simply have to deal with. That is not what happened on my first visit here." Trustpilot
"Every televisit I have had has been thorough, helpful, and pleasant. I don't feel rushed, all my questions are answered and everything is explained clearly." Trustpilot
"I am being required to schedule and pay for another $150 appointment simply to get refills on prescriptions I have been taking and receiving refills for over three years." Trustpilot
"I cannot text while at work and did not confirm again through text within 5 hours. Awful system!" Trustpilot
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Allara Health | 7.7 | 7.8 |
| Midi Health | 7.6 | 7.0 |
| Evernow | 7.6 | 7.9 |
| Alloy | 7.4 | 8.0 |
| Winona | 7.3 | 8.1 |
Pricing
| Item | Detail |
|---|---|
| Model | Midi bills your insurance for each visit, or charges a self-pay price per visit. |
| What usually drives cost | For Midi, cost depends on your plan's copay and deductible, how many follow-up visits you need, and whether your pharmacy coverage pays for your medications. |
| What to ask before you buy | Ask Midi what your plan will charge for a first visit and a follow-up, and how often you need a visit to keep refills going. |
| Note | Medicare is out of network and Medicaid is not accepted. HSA and FSA cards work. |
| Published pricing | Midi lists self-pay prices of $250 for a 30-minute first visit and $150 for a 15-minute return visit. |
Leadership
Joanna StroberCo-founder and CEO
Sharon MeersPresident and co-founder- Kathleen Jordan, MDCo-founder and Chief Medical Officer
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.